Nathalie Belmonte

Nathalie Belmonte has extensive work experience in the biotechnology and research field. Nathalie is currently serving as the SVP Research & Translation for Quell Therapeutics since April 2020. Prior to this, Nathalie worked at Promethera Biosciences where they held multiple roles including COO (October 2019 to April 2020), VP Product Development (May 2018 to October 2019), and Sr Director R&D (December 2017 to October 2019). Earlier in their career, they held positions at TxCell, where they served as VP, R&D (date unspecified, 2015 to 2017) and New products and Cell Processing Director (date unspecified, 2013 to November 2015). Nathalie also worked as an R&D manager at TxCell from 2006 to 2012. Their experience also includes a post-doctoral role at INSERM U638 from January 2006 to August 2006 and a post-doctoral role at TIGET from September 2002 to November 2004.

Nathalie Belmonte pursued their education at Université Côte d'Azur from 1998 to 2002, where they completed their PhD in Cellular and Molecular Biology.